UAE Announces New Rules To End Medicine Monopolies With Multiple Agents Per Drug

2026-02-24 02:17:49

(MENAFN- Khaleej Times) This step is the first of its kind in the healthcare sector to strengthen drug security

PUBLISHED: Tue 24 Feb 2026, 1:31 PM UPDATED: Tue 24 Feb 2026, 1:47 PM

By:
Khaleej Times Staff

Add as a preferred
source on Google

The Emirates Drug Establishment has announced measures to end the monopoly of medical products in the UAE.

The Establishment announced that the new mechanism requires pharmaceutical companies to appoint more than one agent for each medical product.

Recommended For You White House says Trump's first option on Iran is diplomacy

This step is the first of its kind in the healthcare sector to strengthen drug security.

Stay up to date with the latest news. Follow KT on WhatsApp Channels.

The new mechanism aims to end monopolistic practices and ensure the continuous availability of medical products.

The mechanism helps reduce the risks of supply disruptions during emergencies and crises.

It supports pharmaceutical investment and enhances the UAE's global competitiveness.

ALSO READ

Medicine prices in UAE under review as officials admit cost gap
UAE issues new law on veterinary products, bans trade of fake, unsafe animal drugs

MENAFN24022026000049011007ID1110784107

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.